News
Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...
Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial.
Penny Stock Under Rs 3: The Almost Debt-free Stock Locked in 5% Upper Circuit, Company Posts 17.38% Revenue Growth and 46.63% Net Profit Jump in Q1FY26 ResultsSpright Agro Limited has been reinforcing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results